CDK9 inhibition strategy defines distinct sets of target genes

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Garriga, Judit ^a   Graña, Xavier ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CDK9; CDKs; Control of gene expression; RNA polymerase II; Transcription

Indexed keywords

CYCLIN DEPENDENT KINASE 9; FLAVONOID; FLAVOPIRIDOL; PIPERIDINE DERIVATIVE; PROTEIN KINASE INHIBITOR; RNA POLYMERASE II; SMALL INTERFERING RNA;

ANTAGONISTS AND INHIBITORS; ASTROCYTE; CHEMISTRY; CLUSTER ANALYSIS; DNA MICROARRAY; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; PHOSPHORYLATION; TRANSFORMED CELL LINE;

ASTROCYTES; CELL LINE, TRANSFORMED; CLUSTER ANALYSIS; CYCLIN-DEPENDENT KINASE 9; FIBROBLASTS; FLAVONOIDS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MOLECULAR TARGETED THERAPY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PIPERIDINES; PROTEIN KINASE INHIBITORS; RNA POLYMERASE II; RNA, SMALL INTERFERING;

EID: 84902076203     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-301     Document Type: Article

References (26)

1. Cellular control of gene expression by T-type cyclin/CDK9 complexes. Garriga J, Graña X, Gene 2004 337 15 23 15276198
2. P-TEFb- the final frontier. Kohoutek J, Cell Div 2009 4 19 10.1186/1747-1028-4-19 19723344
3. Controlling the elongation phase of transcription with P-TEFb. Peterlin BM, Price DH, Mol Cell 2006 23 297 305 10.1016/j.molcel.2006.06.014 16885020
4. Phosphorylation site specificity of the CDC2-related kinase PITALRE. Garriga J, Segura E, Mayol X, Grubmeyer C, Graña X, Biochem J 1996 320 983 989 9003389
5. Phosphorylation and functions of the RNA polymerase II CTD. Phatnani HP, Greenleaf AL, Genes Dev 2006 20 2922 2936 10.1101/gad.1477006 17079683
6. Selective control of gene expression by CDK9 in human cells. Garriga J, Xie H, Obradovic Z, Graña X, J Cell Physiol 2010 222 200 208 10.1002/jcp.21938 19780058
7. Complex effects of flavopiridol on the expression of primary response genes. Keskin H, Garriga J, Georlette D, Graña X, Cell Div 2012 7 11 10.1186/1747-1028-7-11 22458775
8. Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex. Biglione S, Byers SA, Price JP, Nguyen VT, Bensaude O, Price DH, Maury W, Retrovirology 2007 4 47 10.1186/1742-4690-4-47 17625008
9. CDK9/cyclin T1: a host cell target for antiretroviral therapy. Klebl B, Choidas A, Futur Virol 2006 1 317 330 10.2217/17460794.1.3.317
10. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes. Salerno D, Hasham MG, Marshall R, Garriga J, Tsygankov AY, Graña X, Gene 2007 405 65 78 10.1016/j.gene.2007.09.010 17949927
11. Cyclin-dependent kinase-9: an RNAPII kinase at the nexus of cardiac growth and death cascades. Sano M, Schneider MD, Circ Res 2004 95 867 876 10.1161/01.RES.0000146675.88354.04 15514168
12. Mechanism and regulation of transcriptional elongation and termination by RNA polymerase II. Shilatifard A, Conaway JW, Conaway RC, Curr Opin Genet Dev 1997 7 199 204 10.1016/S0959-437X(97)80129-3 9115429
13. Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology. Wang S, Fischer PM, Trends Pharmacol Sci 2008 29 302 313 10.1016/j.tips.2008.03.003 18423896
14. The super elongation complex (SEC) and MLL in development and disease. Smith E, Lin C, Shilatifard A, Genes Dev 25 661 672
15. Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol. Lam LT, Pickeral OK, Peng AC, Rosenwald A, Hurt EM, Giltnane JM, Averett LM, Zhao H, Davis RE, Sathyamoorthy M, Wahl LM, Harris ED, Mikovits JA, Monks AP, Hollingshead MG, Sausville EA, Staudtl LM, Genome Biol 2001 2 10 RESEARCH0041.1-0041.11
16. Transcriptional signature of flavopiridol-induced tumor cell death. Lü X, Burgan WE, Cerra MA, Chuang EY, Tsai MH, Tofilon PJ, Camphausen K, Mol Cancer Ther 2004 3 861 872 15252147
17. Cyclin T2 is essential for mouse embryogenesis. Kohoutek J, Li Q, Blazek D, Luo Z, Jiang H, Peterlin BM, Mol Cell Biol 2009 29 3280 3285 10.1128/MCB.00172-09 19364821
18. A role for cdk9-cyclin k in maintaining genome integrity. Yu DS, Cortez D, Cell Cycle 2011 10 28 32 10.4161/cc.10.1.14364 21200140
19. Induction of the HIV-1 Tat co-factor cyclin T1 during monocyte differentiation is required for the regulated expression of a large portion of cellular mRNAs. Yu W, Wang Y, Shaw CA, Qin XF, Rice AP, Retrovirology 2006 3 32 10.1186/1742-4690-3-32 16764723
20. Flavopiridol protects against inflammation by attenuating leukocyte-endothelial interaction via inhibition of cyclin-dependent kinase 9. Schmerwitz UK, Sass G, Khandoga AG, Joore J, Mayer BA, Berberich N, Totzke F, Krombach F, Tiegs G, Zahler S, Vollmar AM, Fürst R, Arterioscler Thromb Vasc Biol 2011 31 280 288 10.1161/ATVBAHA.110.213934 21088252
21. Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. Hartman ZC, Kiang A, Everett RS, Serra D, Yang XY, Clay TM, Amalfitano A, J Virol 2007 81 1796 1812 10.1128/JVI.01936-06 17121790
22. Cyclin E and SV40 small T antigen cooperate to bypass quiescence and contribute to transformation by activating CDK2 in human fibroblasts. Sotillo E, Garriga J, Kurimchak A, Graña X, J Biol Chem 2008 283 11280 11292 10.1074/jbc.M709055200 18276582
23. Coordinated activation of the origin licensing factor CDC6 and CDK2 in resting human fibroblasts expressing SV40 small T antigen and cyclin E. Sotillo E, Garriga J, Padgaonkar A, Kurimchak A, Cook J, Graña X, J Biol Chem 2009 284 14126 14135 10.1074/jbc.M900687200 19321444
24. Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation. He N, Pezda AC, Zhou Q, Mol Cell Biol 2006 26 7068 7076 10.1128/MCB.00778-06 16980611
25. Creation of human tumour cells with defined genetic elements. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA, Nature 1999 400 464 468 10.1038/22780 10440377
26. Cluster analysis and display of genome-wide expression patterns. Eisen MB, Spellman PT, Brown PO, Botstein D, Proc Natl Acad Sci U S A 1998 95 14863 14868 10.1073/pnas.95.25.14863 9843981